IgM repertoire biodiversity is reduced in HIV-1 infection and systemic lupus erythematosus

Frontiers in Immunology

Volumn 4, Issue NOV, 2013, Pages

  Yin, Li ^a,b   Hou, Wei ^b   Liu, Li ^b   Cai, Yunpeng ^b   Wallet, Mark Andrew ^a,b   Gardner, Brent Paul ^a   Chang, Kaifen ^a   Lowe, Amanda Catherine ^a   Rodriguez, Carina Adriana ^c   Sriaroon, Panida ^c   Farmerie, William George ^b   Sleasman, John William ^c,d   Goodenow, Maureen Michels ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biodiversity; HIV 1; IgM antibody transcriptome repertoire; IgM memory B cells; Na ve B cells; Pyrosequencing; Somatic hypermutation; Systemic lupus erythematosus

Indexed keywords

EID: 84890365250     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00373     Document Type: Review

References (100)

1. Lipsky PE. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol (2001) 2:764-6. doi: 10.1038/ni0901-764
2. Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol (2009) 9:235-45. doi:10.1038/nri2524
3. Ho J, Moir S, Malaspina A, Howell ML, Wang W, DiPoto AC, et al. Two overrepresented B cell populations in HIV-infected individuals undergo apoptosis by different mechanisms. Proc Natl Acad Sci U S A (2006) 103:19436-41. doi:10.1073/pnas.0609515103
4. Moir S, Ho J, Malaspina A, Wang W, DiPoto AC, O'Shea MA, et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J Exp Med (2008) 205:1797-805. doi:10.1084/jem.20072683
5. Rodriguez-Bayona B, Ramos-Amaya A, Perez-Venegas JJ, Rodriguez C, Brieva JA. Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients. Arthritis Res Ther (2010) 12:R108. doi:10.1186/ar3042
6. Yurasov S, Wardemann H, Hammersen J, Tsuiji M, Meffre E, Pascual V, et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med (2005) 201:703-11. doi:10.1084/jem.20042251
7. Brenchley JM, Price DA, Douek DC. HIV disease: fallout from a mucosal catastrophe? Nat Immunol (2006) 7:235-9. doi:10.1038/ni1316
8. Jacobson MA, Khayam-Bashi H, Martin JN, Black D, Ng V. Effect of long-term highly active antiretroviral therapy in restoring HIV-induced abnormal B-lymphocyte function. J Acquir Immune Defic Syndr (2002) 31:472-7. doi:10.1097/00126334-200212150-00003
9. Jacobi AM, Diamond B. Balancing diversity and tolerance: lessons from patients with systemic lupus erythematosus. J Exp Med (2005) 202:341-4. doi:10.1084/jem.20050221
10. Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, Bemben LA, et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature (2005) 437:376-80. doi:10.1038/nature03959
11. Bomsel M, Heyman M, Hocini H, Lagaye S, Belec L, Dupont C, et al. Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. Immunity (1998) 9:277-87. doi:10.1016/S1074-7613(00)80610-X
12. Sheppard NC, Bates AC, Sattentau QJ. A functional human IgM response to HIV-1 Env after immunization with NYVAC HIV C. AIDS (2007) 21:524-7. doi:10.1097/QAD.0b013e32803277f9
13. Toran JL, Kremer L, Sanchez-Pulido L, de Alboran IM, del RG, Llorente M, et al. Molecular analysis of HIV-1 gp120 antibody response using isotype IgM and IgG phage display libraries from a long-term non-progressor HIV-1-infected individual. Eur J Immunol (1999) 29:2666-75. doi:10.1002/(SICI)1521-4141(199909)29:09<2666::AID-IMMU2666>3.0.CO;2-Q
14. Chen W, Zhu Z, Liao H, Quinnan GV Jr, Broder CC, Haynes BF, et al. Cross-reactive human IgM-derived monoclonal antibodies that bind to HIV-1 envelope glycoproteins. Viruses (2010) 2:547-65. doi:10.3390/v2020547
15. Wolbank S, Kunert R, Stiegler G, Katinger H. Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12. J Virol (2003) 77:4095-103. doi:10.1128/JVI.77.7.4095-4103.2003
16. Cardoso RM, Zwick MB, Stanfield RL, Kunert R, Binley JM, Katinger H, et al. Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Immunity (2005) 22:163-73. doi:10.1016/j.immuni.2004.12.011
17. Haynes BF, Fleming J, St Clair EW, Katinger H, Stiegler G, Kunert R, et al. Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science (2005) 308:1906-8. doi:10.1126/science.1111781
18. Kopelman RG, Zolla-Pazner S. Association of human immunodeficiency virus infection and autoimmune phenomena. Am J Med (1988) 84:82-8. doi:10.1016/0002-9343(88)90012-5
19. Massabki PS, Accetturi C, Nishie IA, da Silva NP, Sato EI, Andrade LE. Clinical implications of autoantibodies in HIV infection. AIDS (1997) 11:1845-50. doi:10.1097/00002030-199715000-00009
20. Ofek G, Tang M, Sambor A, Katinger H, Mascola JR, Wyatt R, et al. Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J Virol (2004) 78:10724-37. doi:10.1128/JVI.78.19.10724-10737.2004
21. Petrovas C, Vlachoyiannopoulos PG, Kordossis T, Moutsopoulos HM. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI. J Autoimmun (1999) 13:347-55. doi:10.1006/jaut.1999.0324
22. Saphire EO, Parren PW, Pantophlet R, Zwick MB, Morris GM, Rudd PM, et al. Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design. Science (2001) 293:1155-9. doi:10.1126/science.1061692
23. Stanfield RL, Gorny MK, Williams C, Zolla-Pazner S, Wilson IA. Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D. Structure (2004) 12:193-204. doi:10.1016/j.str.2004.01.003
24. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science (2003) 301:1374-7. doi:10.1126/science.1086907
25. Zwick MB, Labrijn AF, Wang M, Spenlehauer C, Saphire EO, Binley JM, et al. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J Virol (2001) 75:10892-905. doi:10.1128/JVI.75.24.12198-12208.2001
26. Buchacher A, Predl R, Strutzenberger K, Steinfellner W, Trkola A, Purtscher M, et al. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. AIDS Res Hum Retroviruses (1994) 10:359-69. doi:10.1089/aid.1994.10.359
27. Gorny MK, Conley AJ, Karwowska S, Buchbinder A, Xu JY, Emini EA, et al. Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody. J Virol (1992) 66:7538-42.
28. Scheid JF, Mouquet H, Feldhahn N, Seaman MS, Velinzon K, Pietzsch J, et al. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature (2009) 458:636-40. doi:10.1038/nature07930
29. Bomsel M, Pastori C, Tudor D, Alberti C, Garcia S, Ferrari D, et al. Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells. AIDS (2007) 21:13-22. doi:10.1097/QAD.0b013e328011049b
30. Devito C, Broliden K, Kaul R, Svensson L, Johansen K, Kiama P, et al. Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J Immunol (2000) 165:5170-6.
31. Devito C, Hinkula J, Kaul R, Lopalco L, Bwayo JJ, Plummer F, et al. Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. AIDS (2000) 14:1917-20. doi:10.1097/00002030-200009080-00006
32. Nguyen M, Pean P, Lopalco L, Nouhin J, Phoung V, Ly N, et al. HIV-specific antibodies but not T-cell responses are associated with protection in seronegative partners of HIV-1-infected individuals in Cambodia. J Acquir Immune Defic Syndr (2006) 42:412-9. doi:10.1097/01.qai.0000222289.97825.35
33. Koshino K, Tokano Y, Hishikawa T, Sekigawa I, Takasaki Y, Hashimoto H. Detection of antibodies to HIV-1 gp41-and HLA class II antigen-derived peptides in SLE patients. Scand J Rheumatol (1995) 24:288-92. doi:10.3109/03009749509095165
34. Hamatake M, Komano J, Urano E, Maeda F, Nagatsuka Y, Takekoshi M. Inhibition of HIV replication by a CD4-reactive Fab of an IgM clone isolated from a healthy HIV-seronegative individual. Eur J Immunol (2010) 40:1504-9. doi:10.1002/eji.200939479
35. Lobo PI, Schlegel KH, Yuan W, Townsend GC, White JA. Inhibition of HIV-1 infectivity through an innate mechanism involving naturally occurring IgM anti-leukocyte autoantibodies. J Immunol (2008) 180:1769-79.
36. Campbell A. Save those molecules: molecular biodiversity and life. J Appl Ecol (2003) 40:193-203. doi:10.1046/j.1365-2664.2003.00803.x
37. Newton AC. Forest Ecology and Preservation: A Handbook of Techniques. New York: Oxford University Press (1999).
38. Bimber BN, Burwitz BJ, O'Connor S, Detmer A, Gostick E, Lank SM, et al. Ultradeep pyrosequencing detects complex patterns of CD8+ T-lymphocyte escape in simian immunodeficiency virus-infected macaques. J Virol (2009) 83:8247-53. doi:10.1128/JVI.00897-09
39. Boyd SD, Marshall EL, Merker JD, Maniar JM, Zhang LN, Sahaf B, et al. Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing. Sci Transl Med (2009) 1:12ra23. doi:10.1126/scitranslmed.3000540
40. Glanville J, Zhai W, Berka J, Telman D, Huerta G, Mehta GR, et al. Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire. Proc Natl Acad Sci U S A (2009) 106:20216-21. doi:10.1073/pnas.0909775106
41. Weinstein JA, Jiang N, White RA III, Fisher DS, Quake SR. High-throughput sequencing of the zebrafish antibody repertoire. Science (2009) 324:807-10. doi:10.1126/science.1170020
42. Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum (2012) 64:2677-86. doi:10.1002/art.34473
43. Bossuyt X, Marti GE, Fleisher TA. Comparative analysis of whole blood lysis methods for flow cytometry. Cytometry (1997) 30:124-33. doi:10.1002/(SICI)1097-0320(19970615)30:3<124::AID-CYTO3>3.0.CO;2-L
44. Gokmen E, Raaphorst FM, Boldt DH, Teale JM. Ig heavy chain third complementarity determining regions (H CDR3s) after stem cell transplantation do not resemble the developing human fetal H CDR3s in size distribution and Ig gene utilization. Blood (1998) 92:2802-14.
45. IMGT website. (2012). Available from: http://www.imgt.org
46. Lefranc MP, Duprat E, Kaas Q, Tranne M, Thiriot A, Lefranc G. IMGT unique numbering for MHC groove G-DOMAIN and MHC superfamily (MhcSF) G-LIKE-DOMAIN. Dev Comp Immunol (2005) 29:917-38. doi:10.1016/j.dci.2005.03.003
47. Crooks GE, Hon G, Chandonia JM, Brenner SE. WebLogo: a sequence logo generator. Genome Res (2004) 14:1188-90. doi:10.1101/gr.849004
48. Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 157:105-32. doi:10.1016/0022-2836(82)90515-0
49. Yousfi MM, Giudicelli V, Chaume D, Lefranc MP. IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V-J and V-D-J JUNCTIONs. Bioinformatics (2004) 20(Suppl 1):i379-85. doi:10.1093/bioinformatics/bth945
50. Link JM, Schroeder HW Jr. Clues to the etiology of autoimmune diseases through analysis of immunoglobulin genes. Arthritis Res (2002) 4:80-3. doi:10.1186/ar393
51. Wu YC, Kipling D, Leong HS, Martin V, Ademokun AA, Dunn-Walters DK. High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations. Blood (2010) 116:1070-8. doi:10.1182/blood-2010-03-275859
52. Dunn-Walters DK, Isaacson PG, Spencer J. Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. J Exp Med (1995) 182:559-66. doi:10.1084/jem.182.2.559
53. Gilles A, Meglecz E, Pech N, Ferreira S, Malausa T, Martin JF. Accuracy and quality assessment of 454 GS-FLX Titanium pyrosequencing. BMC Genomics (2011) 12:245. doi:10.1186/1471-2164-12-245
54. Klein U, Kuppers R, Rajewsky K. Evidence for a large compartment of IgM-expressing memory B cells in humans. Blood (1997) 89:1288-98.
55. Sun Y, Cai Y, Liu L, Yu F, Farrell ML, McKendree W, et al. ESPRIT: estimating species richness using large collections of 16S rRNA pyrosequences. Nucleic Acids Res (2009) 37:e76. doi:10.1093/nar/gkp285
56. Yin L, Liu L, Sun Y, Hou W, Lowe AC, Gardner BP, et al. High-resolution deep sequencing reveals biodiversity, population structure, and persistence of HIV-1 quasispecies within host ecosystems. Retrovirology (2012) 9:108. doi:10.1186/1742-4690-9-108
57. Kou ZC, Puhr JS, Wu SS, Goodenow MM, Sleasman JW. Combination antiretroviral therapy results in a rapid increase in T cell receptor variable region beta repertoire diversity within CD45RA CD8 T cells in human immunodeficiency virus-infected children. J Infect Dis (2003) 187:385-97. doi:10.1086/367674
58. Bonsignori M, Hwang KK, Chen X, Tsao CY, Morris L, Gray E, et al. Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors. J Virol (2011) 85:9998-10009. doi:10.1128/JVI.05045-11
59. Corti D, Langedijk JP, Hinz A, Seaman MS, Vanzetta F, Fernandez-Rodriguez BM, et al. Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals. PLoS One (2010) 5:e8805. doi:10.1371/journal.pone.0008805
60. Kunert R, Ruker F, Katinger H. Molecular characterization of five neutralizing anti-HIV type 1 antibodies: identification of nonconventional D segments in the human monoclonal antibodies 2G12 and 2F5. AIDS Res Hum Retroviruses (1998) 14:1115-28. doi:10.1089/aid.1998.14.1115
61. Li Y, O'Dell S, Walker LM, Wu X, Guenaga J, Feng Y, et al. Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01. J Virol (2011) 85:8954-67. doi:10.1128/JVI.00754-11
62. Simek MD, Rida W, Priddy FH, Pung P, Carrow E, Laufer DS, et al. Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm. J Virol (2009) 83:7337-48. doi:10.1128/JVI.00110-09
63. Stiegler G, Kunert R, Purtscher M, Wolbank S, Voglauer R, Steindl F, et al. A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (2001) 17:1757-65. doi:10.1089/08892220152741450
64. Trkola A, Purtscher M, Muster T, Ballaun C, Buchacher A, Sullivan N, et al. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J Virol (1996) 70:1100-8.
65. Walker LM, Phogat SK, Chan-Hui PY, Wagner D, Phung P, Goss JL, et al. Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science (2009) 326:285-9. doi:10.1126/science.1178746
66. Wu X, Yang ZY, Li Y, Hogerkorp CM, Schief WR, Seaman MS, et al. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science (2010) 329:856-61. doi:10.1126/science.1187659
67. Wu X, Zhou T, Zhu J, Zhang B, Georgiev I, Wang C, et al. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science (2011) 333:1593-602. doi:10.1126/science.1207532
68. Zhu Z, Qin HR, Chen W, Zhao Q, Shen X, Schutte R, et al. Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies. J Virol (2011) 85:11401-8. doi:10.1128/JVI.05312-11
69. Hart M, Steel A, Clark SA, Moyle G, Nelson M, Henderson DC, et al. Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease. J Immunol (2007) 178:8212-20.
70. Kardava L, Moir S, Wang W, Ho J, Buckner CM, Posada JG, et al. Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors. J Clin Invest (2011) 121:2614-24. doi:10.1172/JCI45685
71. Longwe H, Gordon S, Malamba R, French N. Characterising B cell numbers and memory B cells in HIV infected and uninfected Malawian adults. BMC Infect Dis (2010) 10:280. doi:10.1186/1471-2334-10-280
72. Titanji K, De MA, Cagigi A, Thorstensson R, Grutzmeier S, Atlas A, et al. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood (2006) 108:1580-7. doi:10.1182/blood-2005-11-013383
73. Seifert M, Kuppers R. Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation. J Exp Med (2009) 206:2659-69. doi:10.1084/jem.20091087
74. Weller S, Braun MC, Tan BK, Rosenwald A, Cordier C, Conley ME, et al. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood (2004) 104:3647-54. doi:10.1182/blood-2004-01-0346
75. Griffin DO, Holodick NE, Rothstein TL. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-. J Exp Med (2011) 208:67-80. doi:10.1084/jem.20101499
76. Tangye SG, Good KL. Human IgM+CD27+ B cells: memory B cells or "memory" B cells? J Immunol (2007) 179:13-9.
77. Wei C, Anolik J, Cappione A, Zheng B, Pugh-Bernard A, Brooks J, et al. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol (2007) 178:6624-33.
78. Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med (1998) 188:1679-89. doi:10.1084/jem.188.9.1679
79. Weston-Bell N, Townsend M, Di GG, Forconi F, Sahota SS. Defining origins of malignant B cells: a new circulating normal human IgM(+)D(+) B-cell subset lacking CD27 expression and displaying somatically mutated IGHV genes as a relevant memory population. Leukemia (2009) 23:2075-80. doi:10.1038/leu.2009.178
80. Medina F, Segundo C, Campos-Caro A, Gonzalez-Garcia I, Brieva JA. The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood (2002) 99:2154-61. doi:10.1182/blood.V99.6.2154
81. Minges Wols HA. Plasma cells. In: Encyclopedia Life Science. John Wiley & Sons, Ltd. (2006). p. 1-8. doi:10.1038/npg.els.0004030
82. Blanchard-Rohner G, Pulickal AS, Jol-van der Zijde CM, Snape MD, Pollard AJ. Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humans. Blood (2009) 114:4998-5002. doi:10.1182/blood-2009-03-211052
83. De Milito A, Morch C, Sonnerborg A, Chiodi F. Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS (2001) 15:957-64. doi:10.1097/00002030-200105250-00003
84. Jacobi AM, Reiter K, Mackay M, Aranow C, Hiepe F, Radbruch A, et al. Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. Arthritis Rheum (2008) 58:1762-73. doi:10.1002/art.23498
85. Weller S, Mamani-Matsuda M, Picard C, Cordier C, Lecoeuche D, Gauthier F, et al. Somatic diversification in the absence of antigen-driven responses is the hallmark of the IgM+ IgD+ CD27+ B cell repertoire in infants. J Exp Med (2008) 205:1331-42. doi:10.1084/jem.20071555
86. Wu YC, Kipling D, Dunn-Walters DK. Age-related changes in human peripheral blood IGH repertoire following vaccination. Front Immunol (2012) 3:193. doi:10.3389/fimmu.2012.00193
87. Chong Y, Ikematsu H, Yamamoto M, Murata M, Yamaji K, Nishimura M, et al. Increased frequency of CD27-(naive) B cells and their phenotypic alteration in HIV type 1-infected patients. AIDS Res Hum Retroviruses (2004) 20:621-9. doi:10.1089/0889222041217455
88. Moir S, Malaspina A, Ho J, Wang W, DiPoto AC, O'Shea MA, et al. Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease. J Infect Dis (2008) 197:572-9. doi:10.1086/526789
89. Sleasman JW, Nelson RP, Goodenow MM, Wilfret D, Hutson A, Baseler M, et al. Immunoreconstitution after ritonavir therapy in children with human immunodeficiency virus infection involves multiple lymphocyte lineages. J Pediatr (1999) 134:597-606. doi:10.1016/S0022-3476(99)70247-7
90. Wallet MA, Rodriguez CA, Yin L, Saporta S, Chinratanapisit S, Hou W, et al. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy. AIDS (2010) 24:1281-90. doi:10.1097/QAD.0b013e328339e228
91. Cohen OJ, Pantaleo G, Lam GK, Fauci AS. Studies on lymphoid tissue from HIV-infected individuals: implications for the design of therapeutic strategies. Springer Semin Immunopathol (1997) 18:305-22. doi:10.1007/BF00813500
92. Wu YC, Kipling D, Dunn-Walters DK. The relationship between CD27 negative and positive B cell populations in human peripheral blood. Front Immunol (2011) 2:81. doi:10.3389/fimmu.2011.00081
93. Carter CC, McNamara LA, Onafuwa-Nuga A, Shackleton M, Riddell J, Bixby D, et al. HIV-1 utilizes the CXCR4 chemokine receptor to infect multipotent hematopoietic stem and progenitor cells. Cell Host Microbe (2011) 9:223-34. doi:10.1016/j.chom.2011.02.005
94. Koka PS, Reddy ST. Cytopenias in HIV infection: mechanisms and alleviation of hematopoietic inhibition. Curr HIV Res (2004) 2:275-82. doi:10.2174/1570162043351282
95. Barbas CF III, Collet TA, Amberg W, Roben P, Binley JM, Hoekstra D, et al. Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries. J Mol Biol (1993) 230:812-23. doi:10.1006/jmbi.1993.1203
96. Barassi C, Lazzarin A, Lopalco L. CCR5-specific mucosal IgA in saliva and genital fluids of HIV-exposed seronegative subjects. Blood (2004) 104:2205-6. doi:10.1182/blood-2004-06-2134
97. Lopalco L. Natural anti-CCR5 antibodies in HIV-infection and-exposure. J Transl Med (2010) 9(Suppl 1):S4. doi:10.1186/1479-5876-9-S1-S4
98. Lopalco L, Barassi C, Paolucci C, Breda D, Brunelli D, Nguyen M, et al. Predictive value of anti-cell and anti-human immunodeficiency virus (HIV) humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin. J Gen Virol (2005) 86:339-48. doi:10.1099/vir.0.80585-0
99. Kunert R, Wolbank S, Stiegler G, Weik R, Katinger H. Characterization of molecular features, antigen-binding, and in vitro properties of IgG and IgM variants of 4E10, an anti-HIV type 1 neutralizing monoclonal antibody. AIDS Res Hum Retroviruses (2004) 20:755-62. doi:10.1089/0889222041524571
100. Morris L, Chen X, Alam M, Tomaras G, Zhang R, Marshall DJ, et al. Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting. PLoS One (2011) 6:e23532. doi:10.1371/journal.pone.0023532